Fernando Hurtado de Mendoza

Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial

Ruth Pettengell, Bertrand Coiffier, Geetha Narayanan et al. · The Lancet Oncology · 2012 · 120 citations

Medicine, Oncology, Pharmacology +14

Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: Rationale for future randomised trials in human papilloma virus-negative disease

Kevin J. Harrington, A. Berrier, Martin Robinson et al. · European Journal of Cancer · 2012 · 118 citations

Medicine, Oncology, Radiation Oncology +7

EBV‐positive diffuse large B‐cell lymphoma of the elderly: A case series from Peru

Brady Beltrán, Jorge J. Castillo, Domingo Morales et al. · American Journal of Hematology · 2011 · 74 citations · Full text

Medicine, Hematology, Pathology +16

Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes

Gabriel N. Hortobágyi, Henry Gómez, Rubi K. Li et al. · Breast Cancer Research and Treatment · 2010 · 66 citations · Full text

Medicine, Oncology, Pharmacology +11

Epstein–Barr virus as a prognostic factor in<i>de novo</i>nodal diffuse large B-cell lymphoma

Domingo Morales, Brady Beltrán, Fernando Hurtado de Mendoza et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2009 · 52 citations

Medicine, Oncology, Pathology +15